Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 1873
Newswise: Brains of pairs of animals synchronize during social interaction

Article ID: 714704

Brains of pairs of animals synchronize during social interaction

University of California, Los Angeles (UCLA), Health Sciences

UCLA researchers have published a Cell study showing that the brains of pairs of animals synchronize during social situations. The level of synchronization actually predicted how much the animals would interact.

Released:
20-Jun-2019 2:05 PM EDT
Open in New Tab
Comment
Newswise: Study shows more effective method for detecting prostate cancer
  • Embargo expired:
    12-Jun-2019 11:00 AM EDT

Article ID: 714138

Study shows more effective method for detecting prostate cancer

University of California, Los Angeles (UCLA), Health Sciences

Each year, 1M men in the U.S. undergo biopsies for prostate cancer. UCLA physicians have found that a new biopsy method, which includes biopsy guided by magnetic resonance imaging (MRI), can be used together with the traditional method to increase the rate of prostate cancer detection.

Released:
10-Jun-2019 1:05 PM EDT
Open in New Tab
Comment
Newswise: UCLA WORLD Policy Analysis Center finds progress on rights of persons with disabilities, but gaps remain leaving millions behind
  • Embargo expired:
    11-Jun-2019 12:05 AM EDT

Article ID: 714112

UCLA WORLD Policy Analysis Center finds progress on rights of persons with disabilities, but gaps remain leaving millions behind

University of California, Los Angeles (UCLA), Health Sciences

Twelve years after the landmark Convention on the Rights of Persons with Disabilities, UCLA WORLD Policy Analysis Center finds evidence of marked progress -- but gaps remain leaving more than 160 million people behind

Released:
7-Jun-2019 11:30 AM EDT
Open in New Tab
Comment

Law and Public Policy

Newswise: UCLA researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer
  • Embargo expired:
    6-Jun-2019 11:00 AM EDT

Article ID: 713970

UCLA researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer

University of California, Los Angeles (UCLA), Health Sciences

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

Released:
5-Jun-2019 12:15 PM EDT
Open in New Tab
Comment
uclahealthlogo.gif
  • Embargo expired:
    3-Jun-2019 10:45 AM EDT

Article ID: 713648

Traditional chemotherapy still gold standard over new targeted therapy for HER2-positive breast cancers

University of California, Los Angeles (UCLA), Health Sciences

Results of a phase 3 clinical trial by researchers at UCLA’s Jonsson Comprehensive Cancer Center found that women with HER2-positive breast cancer had significantly better response rates, but more severe side effects, when they were treated with traditional neoadjuvant chemotherapy along with dual HER2-targeted blockade, compared to a more novel approach using HER2-targeted chemotherapy plus HER2-targeted blockade.

Released:
3-Jun-2019 10:45 AM EDT
Open in New Tab
Comment
Newswise: Immunotherapy drug improves five-year survival rate of people with advanced lung cancer

Article ID: 713646

Immunotherapy drug improves five-year survival rate of people with advanced lung cancer

University of California, Los Angeles (UCLA), Health Sciences

In a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more than 15% of people with advanced non-small cell lung cancer live for at least five years — and 25% of patients whose tumor cells had a specific protein lived at least that long.

Released:
1-Jun-2019 7:30 AM EDT
Open in New Tab
Comment
Newswise: Adding ribociclib to hormone therapy extends lives of women with most common metastatic breast cancer
  • Embargo expired:
    1-Jun-2019 7:30 AM EDT

Article ID: 713647

Adding ribociclib to hormone therapy extends lives of women with most common metastatic breast cancer

University of California, Los Angeles (UCLA), Health Sciences

A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.

Released:
1-Jun-2019 7:30 AM EDT
Open in New Tab
Comment
Newswise: Waze users’ accident reports could cut emergency response time in half

Article ID: 713493

Waze users’ accident reports could cut emergency response time in half

University of California, Los Angeles (UCLA), Health Sciences

Waze, the crowdsourced traffic application, could potentially help first responders reach a car crash in half the time it currently takes compared with reports received by the California Highway Patrol emergency personnel.

Released:
24-May-2019 2:05 PM EDT
Open in New Tab
Comment
Newswise: Prostate Cancer Research Examines Radiation Protocol for the Whole Pelvis

Article ID: 713121

Prostate Cancer Research Examines Radiation Protocol for the Whole Pelvis

University of California, Los Angeles (UCLA), Health Sciences

In a new study published by European Urology, UCLA researchers and colleagues from ten other institutions examined the protocol for treating aggressive prostate cancer. With aggressive forms of this disease, it is often unclear if radiation therapy should be applied to the prostate alone or to the whole pelvis. The reason a low-dose of radiation may be applied to the whole pelvis is that pelvic lymph nodes may have microscopic cancer cells within them.

Released:
17-May-2019 4:20 PM EDT
Open in New Tab
Comment
Newswise: For-Profit Dialysis Provider Charges Private Insurers Four Times More Than Government Payers

Article ID: 712876

For-Profit Dialysis Provider Charges Private Insurers Four Times More Than Government Payers

University of California, Los Angeles (UCLA), Health Sciences

Private insurers covering people receiving treatment for dialysis paid four times more than government insurance programs such as Medicare paid for the same service. Government programs paid, on average, $248 per dialysis session, compared with $1,041 per session for people with private insurance.

Released:
14-May-2019 4:40 PM EDT
Open in New Tab
Comment

Showing results

110 of 1873

Chat now!